These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 37660616)

  • 21. Predictors of hematological abnormalities in multiple sclerosis patients treated with fingolimod and dimethyl fumarate and impact of treatment switch on lymphocyte and leukocyte count.
    Baharnoori M; Gonzalez CT; Chua A; Diaz-Cruz C; Healy BC; Stankiewicz J; Weiner HL; Chitnis T
    Mult Scler Relat Disord; 2018 Feb; 20():51-57. PubMed ID: 29304497
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Diroximel Fumarate in Relapsing Forms of Multiple Sclerosis: A Profile of Its Use.
    Paik J
    CNS Drugs; 2021 Jun; 35(6):691-700. PubMed ID: 34057708
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Successful treatment with dimethyl fumarate in a child with relapsing-remitting multiple sclerosis.
    Saijo N; Abe Y; Oikawa Y; Okubo Y; Endo W; Numata-Uematsu Y; Takahashi T; Uematsu M
    Brain Dev; 2022 May; 44(5):353-356. PubMed ID: 35058083
    [TBL] [Abstract][Full Text] [Related]  

  • 24. N-doped graphitic C
    Dong C; Zheng Z; Wang Z; He J; Ye Z; Gong X; Lo IMC
    J Hazard Mater; 2021 Aug; 416():125891. PubMed ID: 34492829
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Altered adipokine levels are associated with dimethyl fumarate treatment in multiple sclerosis patients.
    Baharnoori M; Wilson R; Saxena S; Gonzalez CT; Sotiropoulos MG; Keyhanian K; Healy BC; Chitnis T
    Mult Scler Relat Disord; 2021 Nov; 56():103311. PubMed ID: 34655958
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Tolerability and safety of dimethyl fumarate in relapsing multiple sclerosis: a prospective observational multicenter study in a real-life Spanish population.
    Sabin J; Urtiaga S; Pilo B; Thuissard I; Galan V; Sainz de la Maza S; Costa-Frossard L; Gómez-Moreno M; Díaz-Díaz J; Oreja-Guevara C; Martínez-Ginés ML; Lozano A; Borrega L; Ayuso L; Castro A; Sanchez P; Meca-Lallana V; Muñoz C; Casanova I; López de Silanes C; Martín H; Rodriguez-García E; Moreno I; García-Merino JA; Aladro Y;
    J Neurol; 2020 Aug; 267(8):2362-2371. PubMed ID: 32350647
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A novel fumarate, isosorbide di-(methyl fumarate) (IDMF), replicates astrocyte transcriptome responses to dimethyl fumarate (DMF) but specifically down-regulates genes linked to a reactive phenotype.
    Swindell WR; Bojanowski K; Chaudhuri RK
    Biochem Biophys Res Commun; 2020 Nov; 532(3):475-481. PubMed ID: 32892947
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparative effectiveness using a matching-adjusted indirect comparison between delayed-release dimethyl fumarate and fingolimod for the treatment of multiple sclerosis.
    Fox RJ; Chan A; Zhang A; Xiao J; Levison D; Lewin JB; Edwards MR; Marantz JL
    Curr Med Res Opin; 2017 Feb; 33(2):175-183. PubMed ID: 27733070
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dimethyl fumarate impairs differentiated B cells and fosters central nervous system integrity in treatment of multiple sclerosis.
    Traub J; Traffehn S; Ochs J; Häusser-Kinzel S; Stephan S; Scannevin R; Brück W; Metz I; Weber MS
    Brain Pathol; 2019 Sep; 29(5):640-657. PubMed ID: 30706542
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Safety and efficacy of dimethyl fumarate in multiple sclerosis: a multi-center observational study.
    Miclea A; Leussink VI; Hartung HP; Gold R; Hoepner R
    J Neurol; 2016 Aug; 263(8):1626-32. PubMed ID: 27260297
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Improved gastrointestinal profile with diroximel fumarate is associated with a positive impact on quality of life compared with dimethyl fumarate: results from the randomized, double-blind, phase III EVOLVE-MS-2 study.
    Wundes A; Wray S; Gold R; Singer BA; Jasinska E; Ziemssen T; de Seze J; Repovic P; Chen H; Hanna J; Messer J; Miller C; Naismith RT
    Ther Adv Neurol Disord; 2021; 14():1756286421993999. PubMed ID: 33796143
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dimethyl fumarate influences innate and adaptive immunity in multiple sclerosis.
    Diebold M; Sievers C; Bantug G; Sanderson N; Kappos L; Kuhle J; Lindberg RLP; Derfuss T
    J Autoimmun; 2018 Jan; 86():39-50. PubMed ID: 28958667
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dimethyl fumarate selectively reduces memory T cells in multiple sclerosis patients.
    Longbrake EE; Ramsbottom MJ; Cantoni C; Ghezzi L; Cross AH; Piccio L
    Mult Scler; 2016 Jul; 22(8):1061-1070. PubMed ID: 26459150
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Dimethyl Fumarate in Multiple Sclerosis].
    Tanaka M; Shimizu Y
    Brain Nerve; 2017 Sep; 69(9):1041-1046. PubMed ID: 28900067
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pharmacokinetics and Bioavailability of Monomethyl Fumarate Following a Single Oral Dose of Bafiertam™ (Monomethyl Fumarate) or Tecfidera
    Lategan TW; Wang L; Sprague TN; Rousseau FS
    CNS Drugs; 2021 May; 35(5):567-574. PubMed ID: 33797063
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Visible-Light-Responsive Graphitic Carbon Nitride: Rational Design and Photocatalytic Applications for Water Treatment.
    Zheng Q; Durkin DP; Elenewski JE; Sun Y; Banek NA; Hua L; Chen H; Wagner MJ; Zhang W; Shuai D
    Environ Sci Technol; 2016 Dec; 50(23):12938-12948. PubMed ID: 27934277
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Medication adherence and health outcomes in persons with multiple sclerosis treated with dimethyl fumarate.
    Jožef M; Locatelli I; Brecl Jakob G; Rot U; Kos M
    Mult Scler Relat Disord; 2023 Apr; 72():104615. PubMed ID: 36933300
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dimethyl fumarate treatment in multiple sclerosis: Recent advances in clinical and immunological studies.
    Montes Diaz G; Hupperts R; Fraussen J; Somers V
    Autoimmun Rev; 2018 Dec; 17(12):1240-1250. PubMed ID: 30316988
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects Mediated by Dimethyl Fumarate on In Vitro Oligodendrocytes: Implications in Multiple Sclerosis.
    Guerriero C; Puliatti G; Di Marino T; Tata AM
    Int J Mol Sci; 2022 Mar; 23(7):. PubMed ID: 35408975
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Oral Dimethyl Fumarate in Children With Multiple Sclerosis: A Dual-Center Study.
    Makhani N; Schreiner T
    Pediatr Neurol; 2016 Apr; 57():101-4. PubMed ID: 26996405
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.